bupivacaine 0.5% (intrathecal)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for bupivacaine 0.5% (intrathecal), covering 2023-10-31 to 2023-10-31. Get the full timeline:
Most recent: Clinical Trial Update: Effects of Intrathecal Dexmedetomidine as an Adjuvant to Low Dose Hyperbaric 0.5% Bupivacaine [Phase 4]